Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Netflix stock climbs as Trump steps back from Warner Bros takeover fight

Netflix stock climbs as Trump steps back from Warner Bros takeover fight

Netflix shares rose 1.7% to $81.51 after President Trump said he would not intervene in the Warner Bros Discovery bidding dispute, leaving the matter to the Justice Department. Warner Bros Discovery shares fell 1.4%, and Paramount Skydance dropped 2%. Senate hearings this week focused on antitrust issues tied to Warner’s $82.7 billion deal. Investors are watching DOJ review and upcoming shareholder and bid deadlines.
Intel stock price slips as Intel’s GPU push hits a tech selloff — what INTC investors watch next

Intel stock price slips as Intel’s GPU push hits a tech selloff — what INTC investors watch next

Intel shares fell 2.3% to $47.49 in morning trading Thursday, reversing earlier gains as 41.6 million shares changed hands. The drop followed Alphabet’s warning on capital spending and Qualcomm’s weak outlook, which pressured chip stocks across Wall Street. Intel’s chief legal officer sold 20,000 shares on Feb. 2 after performance stock units vested, according to SEC filings. CEO Lip-Bu Tan said Intel is ramping up GPU production to target data centers.
Qualcomm stock price tumbles on weak forecast as memory crunch hits handset outlook

Qualcomm stock price tumbles on weak forecast as memory crunch hits handset outlook

Qualcomm shares fell 9.5% to $134.68 Thursday morning after the company forecast weaker-than-expected revenue and profit, citing a global memory chip shortage. The stock touched $129.98 as the iShares Semiconductor ETF dropped 1.5%. CEO Cristiano Amon said the supply crunch is hurting handset chip sales, a trend expected to last into 2027. Several major banks cut their price targets following the results.
Eli Lilly stock slides after $49 Wegovy copy stirs fresh price-war jitters in obesity drugs

Eli Lilly stock slides after $49 Wegovy copy stirs fresh price-war jitters in obesity drugs

Eli Lilly shares fell 6.2% to $1,038.52 Thursday morning after Hims & Hers Health announced a $49-per-month compounded Wegovy pill, undercutting branded obesity drugs. Novo Nordisk shares also dropped 6.8%. Investors focused on Lilly’s ability to protect margins as cheaper alternatives and new pricing models intensify competition. CFO Lucas Montarce warned price cuts will slow growth despite strong demand.
Palantir stock drops again as AI jitters and valuation doubts bite after earnings whipsaw

Palantir stock drops again as AI jitters and valuation doubts bite after earnings whipsaw

Palantir shares fell 6.8% to $130.11 Thursday morning, extending a two-day slide that erased most of Tuesday’s rally. The drop follows a 12% plunge Wednesday amid concerns over AI-driven valuations and sector volatility. Director Alexander D. Moore disclosed selling 20,000 shares last week. Investors await U.S. economic data next week that could shift rate expectations for growth stocks.
Natural gas price pauses near $3.45 as EIA storage report looms; gas stocks mixed

Natural gas price pauses near $3.45 as EIA storage report looms; gas stocks mixed

U.S. natural gas futures hovered near $3.45/mmBtu Thursday as traders awaited the EIA’s weekly storage update following Monday’s 25.7% price plunge, the steepest since 1995. Analysts expect a record storage withdrawal of up to 379 Bcf for the week ending Jan. 30. March Nymex gas rose 4.65% Wednesday amid a Northeast cold snap. Antero Resources completed its $2.8 billion HG Energy II acquisition, backed by a $1.5 billion loan.
Nvidia stock price edges up as Huang calls AI disruption fears “illogical”

Nvidia stock price edges up as Huang calls AI disruption fears “illogical”

Nvidia shares rose 0.8% to $175.60 Thursday, even as the S&P 500 software and services index lost over $800 billion in value in six sessions amid AI disruption fears. Alphabet projected 2026 capital spending of up to $185 billion, rattling markets and sending the Nasdaq down 1.36% at the open. Microsoft fell 2.6%, while AMD and Broadcom gained. OpenAI launched its Frontier agent service for enterprises.
XRP price slides nearly 12% as bitcoin breaks $70,000; Ripple’s DeFi push draws fresh scrutiny

XRP price slides nearly 12% as bitcoin breaks $70,000; Ripple’s DeFi push draws fresh scrutiny

XRP fell nearly 12% in 24 hours to around $1.37, tracking a broader crypto sell-off after Donald Trump named Kevin Warsh as the next Fed chair. Bitcoin dropped below $70,000 as traders braced for tighter liquidity. Ripple announced Ripple Prime now supports Hyperliquid to expand institutional DeFi access. U.S. jobs data is due Feb. 11, with CPI to follow Feb. 13.
Dow Jones drops nearly 300 points as Alphabet AI spending plan rekindles tech jitters

Dow Jones drops nearly 300 points as Alphabet AI spending plan rekindles tech jitters

The Dow fell 298 points to 49,203 Thursday morning, pulled down by Amazon and Microsoft as tech stocks slumped. Alphabet projected 2026 capital spending could double to as much as $185 billion, raising investor concerns. Qualcomm warned of missing earnings forecasts, sending shares lower. January layoffs hit 108,435, the highest for the month since 2009, with UPS and Amazon leading cuts.
Silver price plunges today as dollar firms and China selling hits metals — what traders watch next

Silver price plunges today as dollar firms and China selling hits metals — what traders watch next

Spot silver plunged 12.8% to $76.94 an ounce by 9:47 a.m. ET Thursday, erasing a brief rally after heavy futures selling and thin liquidity. The iShares Silver Trust ETF fell to $67.39, down from $79.18. Analysts cited profit-taking, a stronger dollar, and easing geopolitical tensions. Attention shifts to upcoming U.S. labor and inflation data after a brief government shutdown.
1 29 30 31 32 33 1,008

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
Go toTop